International issues that are compelling, new or changed in 2024 and of critical interest to healthcare, life sciences, and pharmaceutical companies.
IQVIA presents a global view of key trends, inflection points and challenges which will shape healthcare, and the pharmaceutical market through 2024 and beyond, with a deep dive into the momentous changes that the rise of the obesity market, and the wider renaissance of innovation to treat cardiometabolic conditions will bring to health and healthcare systems globally. Register here today.
3 key takeaways:
Discover more about IQVIA:
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry dedicated to creating intelligent connections that deliver unique and actionable insights. With approximately 86,000 employees, IQVIA conducts operations in more than 100 countries. Learn more at www.iqvia.com.
